POPULATION SURVIVAL
Non-Hodgkin Lymphoma 5-Year Survival Conditional Survival Recent Trends Long-Term Trends Cancer source group Acute Lymphocytic Leukemia (ALL) Acute Monocytic Leukemia (AML-M5) Acute Myeloid Leukemia (AML) Adenocarcinoma of the Esophagus Adenocarcinoma of the Lung and Bronchus All Cancer Sites Combined Anus, Anal Canal & Anorectum Bones and Joints Brain and Other Nervous System Breast Cervix Uteri Chronic Lymphocytic Leukemia (CLL) Chronic Myeloid Leukemia (CML) Chronic Myelomonocytic Leukemia (CMML) Chronic myeloproliferative disorders (CMD) Colon (including Appendix) Colon and Rectum (excluding Appendix) Colon and Rectum (including Appendix) Corpus and Uterus, NOS Diffuse Astrocytoma and Anaplastic Astrocytoma of the Brain and ONS Embryonal Tumors of the Brain and ONS Esophagus Eye and Orbit Floor of Mouth Follicular Subtype of the Thyroid Gallbladder Glioblastoma of the Brain and ONS Gum & other mouth Hodgkin Lymphoma HR-/HER2- Breast Cancer (Female only) HR-/HER2+ Breast Cancer (Female only) HR+/HER2- Breast Cancer (Female only) HR+/HER2+ Breast Cancer (Female only) Kaposi Sarcoma Kidney Kidney and Renal Pelvis Large Cell Carcinoma of the Lung and Bronchus Larynx Leukemia Lip Liver and Intrahepatic Bile Duct Lung and Bronchus Melanoma of the Skin Meningioma of the Brain and ONS Mesothelioma Myelodysplastic syndromes (MDS) Myeloma Non-Hodgkin Lymphoma Oral Cavity and Pharynx Oropharynx & Tonsil Other Glioma of the Brain and ONS Ovary Pancreas Papillary Subtype of the Thyroid Prostate Rectum Renal Pelvis Salivary Gland Small cell carcinoma of the Lung and Bronchus Small Intestine Soft Tissue including Heart Squamous Cell Carcinoma of the Esophagus Squamous Cell Carcinoma of the Lung and Bronchus Stomach Testis Thyroid Tongue Urinary Bladder (Invasive & In Situ) Vagina Vulva
Filters stay in your browser. Some combinations have no estimate.
SEER · SOURCE POPULATIONS
Five-year relative survival Relative survival five years after diagnosis, for the selected source population.
Loading the exact source populations…
Relative survival compares cancer populations with the general population. It is not the percentage of people alive, a treatment effect, or a personal forecast. Diagnosis-period dates were not labeled in the recovered package; see the source notes below.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle